FI920150A0 - Gm-csf-antagonister haerledda fraon karboxylterminala aendan. - Google Patents

Gm-csf-antagonister haerledda fraon karboxylterminala aendan.

Info

Publication number
FI920150A0
FI920150A0 FI920150A FI920150A FI920150A0 FI 920150 A0 FI920150 A0 FI 920150A0 FI 920150 A FI920150 A FI 920150A FI 920150 A FI920150 A FI 920150A FI 920150 A0 FI920150 A0 FI 920150A0
Authority
FI
Finland
Prior art keywords
karboxylterminala
haerledda
antagonister
aendan
fraon
Prior art date
Application number
FI920150A
Other languages
English (en)
Finnish (fi)
Inventor
Gail Foure Seelig
Julie Ellen Scheffler
Paul Phillip Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI920150A0 publication Critical patent/FI920150A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
FI920150A 1989-07-14 1992-01-14 Gm-csf-antagonister haerledda fraon karboxylterminala aendan. FI920150A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37984689A 1989-07-14 1989-07-14
PCT/US1990/003811 WO1991001330A1 (en) 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus

Publications (1)

Publication Number Publication Date
FI920150A0 true FI920150A0 (fi) 1992-01-14

Family

ID=23498958

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920150A FI920150A0 (fi) 1989-07-14 1992-01-14 Gm-csf-antagonister haerledda fraon karboxylterminala aendan.

Country Status (16)

Country Link
US (1) US5475087A (es)
EP (2) EP0482086A1 (es)
JP (1) JPH04503815A (es)
KR (1) KR920701246A (es)
AU (1) AU630496B2 (es)
CA (1) CA2062975A1 (es)
FI (1) FI920150A0 (es)
HU (1) HUT63181A (es)
IE (1) IE902562A1 (es)
IL (1) IL95061A0 (es)
MY (1) MY105946A (es)
NO (1) NO920176L (es)
NZ (1) NZ234479A (es)
PH (1) PH27534A (es)
WO (1) WO1991001330A1 (es)
ZA (1) ZA905480B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060741A1 (en) * 1991-02-11 1992-08-12 Robert S. Greenfield Gm-csf inhibiting oligopeptides
WO1994011404A1 (en) * 1992-11-19 1994-05-26 Dana-Farber Cancer Institute Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) * 1995-02-08 1997-07-11 Stephanois Rech Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) 1995-06-23 1995-07-20 Bresagen Limited Haemopoietic growth factor antagonists and uses therefor
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US8062637B2 (en) * 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
AU2005100402B4 (en) * 2005-05-16 2006-01-12 Novomatic Ag Method for increased chances at an award on a Gaming Machine
KR101486183B1 (ko) 2006-02-08 2015-01-28 모르포테크, 인크. 항원성 ｇｍ-ｃｓｆ 펩티드 및 ｇｍ-ｃｓｆ에 대한 항체
AU2013201228B2 (en) * 2006-02-08 2016-01-21 Eisai, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
EP2402013A1 (en) * 2006-11-21 2012-01-04 Kalobios Pharmaceuticals, Inc. Methods of Treating Chronic Inflammatory Diseases using a GM-CSF Antagonist
US8398972B2 (en) 2006-11-21 2013-03-19 Kalobios Pharmaceuticals, Inc. Methods of treating dementia using a GM-CSF antagonist
TW200918553A (en) * 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
KR20100102108A (ko) 2007-11-13 2010-09-20 에베크 인코포레이티드 ｈＧＭ-ＣＳＦ에 결합하는 모노클로날 항체 및 이를 포함하는 의약 조성물
AU2009329811B2 (en) * 2008-12-22 2016-02-25 The University Of Melbourne Pain treatment
WO2010071924A1 (en) 2008-12-22 2010-07-01 The University Of Melbourne Osteoarthritis treatment
US9901079B2 (en) 2011-08-18 2018-02-27 New York University Inhibition of oncogenic kras-induced GM-CSF production and function
KR20140103122A (ko) * 2011-11-17 2014-08-25 넨키 인스티튜트 오브 익스페리멘탈 바이올로지 신경교종을 치료하기 위한 조성물 및 방법
EP4291380A1 (en) 2021-02-15 2023-12-20 Splifar S.A. Method for applying a seal to a plate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
UA39161C2 (uk) * 1984-07-06 2001-06-15 Новартіс Аг Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
HU9200087D0 (en) 1992-04-28
PH27534A (en) 1993-08-18
HUT63181A (en) 1993-07-28
EP0409091A1 (en) 1991-01-23
NO920176D0 (no) 1992-01-14
US5475087A (en) 1995-12-12
NO920176L (no) 1992-01-14
AU630496B2 (en) 1992-10-29
KR920701246A (ko) 1992-08-11
MY105946A (en) 1995-02-28
IE902562A1 (en) 1991-02-27
IL95061A0 (en) 1991-06-10
WO1991001330A1 (en) 1991-02-07
EP0482086A1 (en) 1992-04-29
AU6148790A (en) 1991-02-22
CA2062975A1 (en) 1991-01-15
NZ234479A (en) 1992-03-26
JPH04503815A (ja) 1992-07-09
ZA905480B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
FI913370A0 (fi) Aeggformad kryddhaollare.
NO902289L (no) Blodproeve-roer.
DE59000343D1 (de) Schaelmesser.
FI920150A0 (fi) Gm-csf-antagonister haerledda fraon karboxylterminala aendan.
DE69017059T2 (de) Mehrplattenspieler.
DE59007379D1 (de) 3-Phenylbenzofuran-2-one.
DE59007974D1 (de) Uretero-Renoskop.
DE59004522D1 (de) Mikrodosiergerät.
DE59005135D1 (de) Formstein.
DE59008431D1 (de) Triazolylsulfonamide.
DE69004689T2 (de) N-fluoropyridinium-pyridin-heptafluorodiborat.
DE59009874D1 (de) Iminosilane.
DE69013427T2 (de) Glyoxyl-Cyclohexendione.
DE59008846D1 (de) Fluorphenylpyrimidine.
DE59007719D1 (de) Pyrazol-3-carbonsäureamide.
DE69008037D1 (de) Satteldecke.
DE69005107D1 (de) Fusskreuz.
DE69001981D1 (de) Kaefigmutter.
ES1010851Y (es) Mueble-bar.
DE59005993D1 (de) Dibenzofuranylbiphenyle.
DE59004564D1 (de) Mappe.
ES1010046Y (es) Senalizador fumigeno.
ES1009934Y (es) Envase -expositor.
ES1009775Y (es) Bielectrodo litotriptor.
ES1009558Y (es) Chimenea-hogar.

Legal Events

Date Code Title Description
FD Application lapsed